Association between metabolic syndrome and myocardial infarction among patients with excess body weight: a systematic review and meta-analysis
- PMID: 38347488
- PMCID: PMC10863149
- DOI: 10.1186/s12889-024-17707-7
Association between metabolic syndrome and myocardial infarction among patients with excess body weight: a systematic review and meta-analysis
Abstract
Background: Cardiovascular diseases (CVDs) are a major cause of morbidity and mortality worldwide. Controversial views exist over the effects of metabolically unhealthy obesity phenotypes on CVDs. This study aimed to perform a meta-analysis to assess the association between metabolic syndrome and myocardial infarction (MI) among individuals with excess body weight (EBW).
Methods: We searched PubMed/Medline, Scopus, and Web of Science databases as of December 9, 2023. Cohort studies involving patients with overweight or obesity that reported the relevant effect measures for the association between metabolic syndrome and MI were included. We excluded studies with incomplete or unavailable original data, reanalysis of previously published data, and those that did not report the adjusted effect sizes. We used the Newcastle Ottawa Scale for quality assessment. Random-effect model meta-analysis was performed. Publication bias was assessed by Begg's test.
Results: Overall, nine studies comprising a total of 61,104 participants were included. There was a significant positive association between metabolic syndrome and MI among those with obesity (hazard ratio (HR): 1.68; 95% confidence interval (CI): 1.27, 2.22). Subgroup analysis showed higher HRs for obesity (1.72; 1.03, 2.88) than overweight (1.58; 1.-13-2.21). Meta-regression revealed no significant association between nationality and risk of MI (p = 0.75). All studies had high qualities. There was no significant publication bias (p = 0.42).
Conclusions: Metabolic syndrome increased the risk of MI in those with EBW. Further studies are recommended to investigate other risk factors of CVDs in EBW, in order to implement preventive programs to reduce the burden of CVD in obesity.
Keywords: Meta-analysis; Metabolic syndrome; Myocardial infarction; Obesity; Overweight; Systematic review.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome.JAMA Intern Med. 2014 Jan;174(1):15-22. doi: 10.1001/jamainternmed.2013.10522. JAMA Intern Med. 2014. PMID: 24217719
-
Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study.Eur J Endocrinol. 2018 Dec 1;179(6):343-352. doi: 10.1530/EJE-18-0356. Eur J Endocrinol. 2018. PMID: 30400019
-
The long-term prognosis of heart diseases for different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies.Endocrine. 2019 Mar;63(3):439-462. doi: 10.1007/s12020-019-01840-0. Epub 2019 Jan 22. Endocrine. 2019. PMID: 30671787
-
Risk of Heart Failure between Different Metabolic States of Health and Weight: A Meta-Analysis of Cohort Studies.Nutrients. 2022 Dec 8;14(24):5223. doi: 10.3390/nu14245223. Nutrients. 2022. PMID: 36558382 Free PMC article.
-
Independent and joint effects of body mass index and metabolic health in mid- and late-life on all-cause mortality: a cohort study from the Swedish Twin Registry with a mean follow-up of 13 Years.BMC Public Health. 2022 Apr 11;22(1):718. doi: 10.1186/s12889-022-13082-3. BMC Public Health. 2022. PMID: 35410261 Free PMC article.
Cited by
-
Metabolic syndrome with mortality and major adverse cardiovascular events in an elderly population.Front Endocrinol (Lausanne). 2025 May 22;16:1570191. doi: 10.3389/fendo.2025.1570191. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40487759 Free PMC article.
-
Effects of different Metabolic Bariatric Surgeries in Testosterone Levels: A Systematic Review and Meta-Analysis.Obes Surg. 2025 May;35(5):1780-1789. doi: 10.1007/s11695-025-07839-z. Epub 2025 Apr 5. Obes Surg. 2025. PMID: 40185956
-
Evaluating atherogenic index of plasma as a predictor for metabolic syndrome: a cross-sectional analysis from Northern Taiwan.Front Endocrinol (Lausanne). 2025 Jan 13;15:1438254. doi: 10.3389/fendo.2024.1438254. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39872319 Free PMC article.
-
Assessment of the Impact of Comorbidities on Outcomes in Non-ST Elevation Myocardial Infarction (NSTEMI) Patients: A Narrative Review.Cureus. 2024 Jul 28;16(7):e65568. doi: 10.7759/cureus.65568. eCollection 2024 Jul. Cureus. 2024. PMID: 39192929 Free PMC article. Review.
-
The effect of obesity phenotype changes on cardiovascular outcomes in adults older than 40 years in the prospective cohort of the Tehran lipids and glucose study (TLGS): joint model of longitudinal and time-to-event data.BMC Public Health. 2024 Apr 23;24(1):1126. doi: 10.1186/s12889-024-18577-9. BMC Public Health. 2024. PMID: 38654182 Free PMC article.
References
-
- Popa S, Moţa M, Popa A, Moţa E, Serafinceanu C, Guja C, et al. Prevalence of overweight/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study. J Endocrinol Investig. 2016;39(9):1045–53. doi: 10.1007/s40618-016-0470-4. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical